Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
Aug 31, 2026 - 00:08:31
Radio and PodcastLive Radio & PodcastsHealth
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Guest: Raphael Schneider, MD, PhD, FRCPC, CIP Multiplex proteomic biomarker panels are redefining how we understand and monitor multiple sclerosis (MS) by capturing interconnected pathways in a single sample. Hear from D...
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Aug 20, 2026 - 00:11:37
Advancing MOGAD Care
Jun 24, 2026 - 00:10:04
Multidisciplinary Coordination in TK2d Diagnosis and Management
Jun 24, 2026 - 00:11:15
Navigating Stem Cell Therapy Conversations in MS
Jun 8, 2026 - 00:04:45
Cognitive Screening in MS: Practical Strategies and Modern Approaches
May 28, 2026 - 00:03:30
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45